نتائج البحث 291-300 من 12614 لعملية البحث عن Severe hyperkalaemia
Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. Durvalumab is FDA approved for treatment in lung ...
A Study Of Vagus Nerve Stimulation (VNS) With Mobility Training For Gait Recovery After Chronic Ischemic Stroke. Rochester, Minn. The purpose of this study is ...
Cell, Serum, and Buccal Bank for Patients with Chronic Myeloid Disorders and Acute Leukemia. Rochester, Minn. This study is being done to store blood, buccal ...
Hyperbaric oxygen therapy. https://www.uptodate.com/contents/search. Accessed April 8, 2022. Novara E, et al. Severe acute dried gangrene in ...
... Chronic Ischemic Stroke ... The purpose of this study is to follow Mayo Clinic patients with severe brachial plexus injuries who underwent upper limb amputation.
All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...
The Specific Aims of this study are: 1. To identify the genetic causes of bicuspid aortic valve disease and its associated thoracic aortic disease. 2. To ...
The primary objective of this study is to investigate the contribution of group 2 innate lymphoid cells (ILC2s) to the immunologic mechanisms of chronic airway ...
... acute hypoxic respiratory failure from all cause in comparison with PaO2 ... acute respiratory failure. COVID-19 and Acute Renal Failure. Jacksonville ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.